Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 300.00% vs 0.00% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 41.75% vs 27.74% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 36.59% vs -24.87% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -70.21% vs -77.62% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Immunovia AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 300.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -20.00% vs 150.00% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 41.75% vs 27.74% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -658.06% vs 106.33% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 36.59% vs -24.87% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 45.83% vs -44.72% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -70.21% vs -77.62% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






